Literature DB >> 7616422

Ligand binding properties of muscarinic acetylcholine receptor subtypes (m1-m5) expressed in baculovirus-infected insect cells.

G Z Dong1, K Kameyama, A Rinken, T Haga.   

Abstract

Five subtypes of muscarinic acetylcholine receptors (m1-m5) have been expressed in insect cells (Spodoptera frugiperda, Sf9) using the baculovirus system. Up to 6 nmol of muscarinic acetylcholine receptors were produced by 1 liter culture; 0.3 to 0.6 (human m1), 3 to 6 (human m2), 2 to 4 (rat m3), 1 to 2 (rat m4) and 0.5 to 1 (human m5) nmol. Pirenzepine, AF-DX116 and hexahidrosiladifenidol showed the highest affinity for the m1, m2 and m3 subtype, respectively, indicating that these receptors expressed in Sf9 cells retain the same substrate specificity as those in mammalian tissues or cultured cells. Among 32 kinds of muscarinic ligands examined in the present studies, prifinium was found to have the highest affinity for the m4 subtype, and pilocarpine, oxotremorine, McN-A343 and promethazine the highest affinity for the m5 subtype, although the differences in the affinities among the five subtypes were less than 10-fold. Alcuronium increased the binding of [3H]N-methylscopalamine to the m2 subtype, but not the m1, m4 and m5 subtypes and only slightly to the m3 subtype. Similar but smaller effects of fangchinoline and tetrandrine were found for [3H]N-methylscopalamine binding to only the m3 subtype. These effects may also be useful for the discrimination of individual subtypes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7616422

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  16 in total

1.  Upregulation of mRNA encoding the M5 muscarinic acetylcholine receptor in human T- and B-lymphocytes during immunological responses.

Authors:  Takeshi Fujii; Yoshihiro Watanabe; Tomoyuki Inoue; Koichiro Kawashima
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

2.  Segment-dependent expression of muscarinic acetylcholine receptors and G-protein coupling in the equine respiratory tract.

Authors:  G Abraham; C Kottke; H Ammer; S Dhein; F R Ungemach
Journal:  Vet Res Commun       Date:  2006-12-15       Impact factor: 2.459

3.  Activation of muscarinic acetylcholine receptors via their allosteric binding sites.

Authors:  J Jakubík; L Bacáková; V Lisá; E E el-Fakahany; S Tucek
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

4.  Interactions between allosteric modulators and 4-DAMP and other antagonists at muscarinic receptors: potential significance of the distance between the N and carboxyl C atoms in the molecules of antagonists.

Authors:  M Lysíková; Z Havlas; S Tucek
Journal:  Neurochem Res       Date:  2001-04       Impact factor: 3.996

5.  Pharmacological characterization of M1 muscarinic acetylcholine receptor-mediated Gq activation in rat cerebral cortical and hippocampal membranes.

Authors:  Yuji Odagaki; Masakazu Kinoshita; Ryoichi Toyoshima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-09       Impact factor: 3.000

6.  Anti-muscarinic adjunct therapy accelerates functional human oligodendrocyte repair.

Authors:  Kavitha Abiraman; Suyog U Pol; Melanie A O'Bara; Guang-Di Chen; Zainab M Khaku; Jing Wang; David Thorn; Bansi H Vedia; Ezinne C Ekwegbalu; Jun-Xu Li; Richard J Salvi; Fraser J Sim
Journal:  J Neurosci       Date:  2015-02-25       Impact factor: 6.167

7.  The muscarinic agonist pilocarpine modifies cocaine-reinforced and food-reinforced responding in rats: comparison with the cholinesterase inhibitor tacrine.

Authors:  Kenneth W Grasing; Haiyang Xu; Jessica Y Idowu
Journal:  Behav Pharmacol       Date:  2019-09       Impact factor: 2.293

8.  Muscarinic excitation of parvalbumin-positive interneurons contributes to the severity of pilocarpine-induced seizures.

Authors:  Feng Yi; Evan DeCan; Kurt Stoll; Eric Marceau; Karl Deisseroth; J Josh Lawrence
Journal:  Epilepsia       Date:  2014-12-13       Impact factor: 5.864

9.  Isolated porcine bronchi provide a reliable model for development of bronchodilator anti-muscarinic agents for human use.

Authors:  G D'Agostino; A M Condino; L Gioglio; F Zonta; M Tonini; A Barbieri
Journal:  Br J Pharmacol       Date:  2008-06-02       Impact factor: 8.739

Review 10.  Update on PET Tracer Development for Muscarinic Acetylcholine Receptors.

Authors:  Marius Ozenil; Jonas Aronow; Marlon Millard; Thierry Langer; Wolfgang Wadsak; Marcus Hacker; Verena Pichler
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.